Epocrates Inc., a vendor of point of care drug reference content available via mobile computing devices, expects in coming days to conduct an initial public offering of stock valued at up to $92.5 million.

The San Mateo, Calif.-based firm previously anticipated proceeds of up to about $55 million and recently raised the IPO's value. The company now expects to sell up to 6.164 million shares between $13 and $15 per share.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access